{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:45:42Z","timestamp":1790397942075,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB841"],"award-info":[{"award-number":["SFB841"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR179-TP04"],"award-info":[{"award-number":["TRR179-TP04"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB841 A6"],"award-info":[{"award-number":["SFB841 A6"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f&amp;#x00FC;r Infektionsforschung","doi-asserted-by":"publisher","award":["TTU HCV"],"award-info":[{"award-number":["TTU HCV"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The combined regulation of a network of inhibitory and activating T cell receptors may be a critical step in the development of chronic HCV infection.\n                    <jats:italic>Ex vivo<\/jats:italic>\n                    HCV MHC class I\u2009+\u2009II tetramer staining and bead-enrichment was performed with baseline and longitudinal PBMC samples of a cohort of patients with acute, chronic and spontaneously resolved HCV infection to assess the expression pattern of the co-inhibitory molecule TIGIT together with PD-1, BTLA, Tim-3, as well as OX40 and CD226 (DNAM-1) of HCV-specific CD4+ T cells, and in a subset of patients of HCV-specific CD8+ T cells. As the main result, we found a higher expression level of TIGIT+ PD-1+ on HCV-specific CD4+ T cells during acute and chronic HCV infection compared to patients with spontaneously resolved HCV infection (p\u2009&lt;\u20090,0001). Conversely, expression of the complementary co-stimulatory receptor of TIGIT, CD226 (DNAM-1) was significantly decreased on HCV-specific CD4+ T cells during chronic infection. The predominant phenotype of HCV-specific CD4+ T cells during acute and chronic infection was TIGIT+, PD-1+, BTLA+, Tim-3\u2212. This comprehensive phenotypic study confirms TIGIT together with PD-1 as a discriminatory marker of dysfunctional HCV-specific CD4+ T cells.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-47024-8","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T06:03:15Z","timestamp":1563861795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules"],"prefix":"10.1038","volume":"9","author":[{"given":"Christin","family":"Ackermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Woost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Peine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Marget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kuntzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Boettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-1938","authenticated-orcid":false,"given":"Julian","family":"Schulze zur Wiesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"key":"47024_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1084\/jem.20100388","volume":"209","author":"J Schulze Zur Wiesch","year":"2012","unstructured":"Schulze Zur Wiesch, J. et al. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. The Journal of experimental medicine 209, 61\u201375 (2012).","journal-title":"The Journal of experimental medicine"},{"key":"47024_CR2","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"R Thimme","year":"2001","unstructured":"Thimme, R. et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. The Journal of experimental medicine 194, 1395\u20131406 (2001).","journal-title":"The Journal of experimental medicine"},{"key":"47024_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer, G. M. & Walker, B. D. Hepatitis C virus infection. N Engl J Med 345, 41\u201352 (2001).","journal-title":"N Engl J Med"},{"key":"47024_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","volume":"12","author":"J Grebely","year":"2012","unstructured":"Grebely, J. et al. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis 12, 408\u2013414 (2012).","journal-title":"Lancet Infect Dis"},{"key":"47024_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","volume":"156","author":"JR Bailey","year":"2019","unstructured":"Bailey, J. R., Barnes, E. & Cox, A. L. Approaches, Progress, and Challenges to Hepatitis C Vaccine Development. Gastroenterology 156, 418\u2013430 (2019).","journal-title":"Gastroenterology"},{"key":"47024_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1126\/science.1088774","volume":"302","author":"A Grakoui","year":"2003","unstructured":"Grakoui, A. et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 302, 659\u2013662 (2003).","journal-title":"Science"},{"key":"47024_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev.micro.58.030603.123836","volume":"58","author":"NH Shoukry","year":"2004","unstructured":"Shoukry, N. H., Cawthon, A. G. & Walker, C. M. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 58, 391\u2013424 (2004).","journal-title":"Annu Rev Microbiol"},{"key":"47024_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.antiviral.2014.11.009","volume":"114","author":"L Holz","year":"2015","unstructured":"Holz, L. & Rehermann, B. T cell responses in hepatitis C virus infection: historical overview and goals for future research. Antiviral Res 114, 96\u2013105 (2015).","journal-title":"Antiviral Res"},{"key":"47024_CR9","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1128\/JVI.02474-07","volume":"82","author":"V Kasprowicz","year":"2008","unstructured":"Kasprowicz, V. et al. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. Journal of virology 82, 3154\u20133160 (2008).","journal-title":"Journal of virology"},{"key":"47024_CR10","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.1128\/JVI.01177-06","volume":"80","author":"S Urbani","year":"2006","unstructured":"Urbani, S. et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. Journal of virology 80, 11398\u201311403 (2006).","journal-title":"Journal of virology"},{"key":"47024_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/j.gastro.2013.10.022","volume":"146","author":"DC Kroy","year":"2014","unstructured":"Kroy, D. C. et al. Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors. Gastroenterology 146, 550\u2013561 (2014).","journal-title":"Gastroenterology"},{"key":"47024_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7326\/0003-4819-158-4-201302190-00003","volume":"158","author":"P Duggal","year":"2013","unstructured":"Duggal, P. et al. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 158, 235\u2013245 (2013).","journal-title":"Ann Intern Med"},{"key":"47024_CR13","doi-asserted-by":"publisher","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","volume":"6","author":"B Bengsch","year":"2010","unstructured":"Bengsch, B. et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 6, e1000947 (2010).","journal-title":"PLoS Pathog"},{"key":"47024_CR14","doi-asserted-by":"publisher","first-page":"e1002045","DOI":"10.1371\/journal.ppat.1002045","volume":"7","author":"V Schlaphoff","year":"2011","unstructured":"Schlaphoff, V. et al. Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS Pathog 7, e1002045 (2011).","journal-title":"PLoS Pathog"},{"key":"47024_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ni969","volume":"4","author":"RA Seder","year":"2003","unstructured":"Seder, R. A. & Ahmed, R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 4, 835\u2013842 (2003).","journal-title":"Nat Immunol"},{"key":"47024_CR16","doi-asserted-by":"crossref","unstructured":"Teigler, J. E. et al. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection. Journal of virology 91 (2017).","DOI":"10.1128\/JVI.01263-17"},{"key":"47024_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston, R. J. et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell 26, 923\u2013937 (2014).","journal-title":"Cancer Cell"},{"key":"47024_CR18","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1172\/JCI80445","volume":"125","author":"JM Chauvin","year":"2015","unstructured":"Chauvin, J. M. et al. TIGIT and PD-1 impair tumor antigen-specific CD8(+) T cells in melanoma patients. J Clin Invest 125, 2046\u20132058 (2015).","journal-title":"J Clin Invest"},{"key":"47024_CR19","doi-asserted-by":"publisher","first-page":"e1371399","DOI":"10.1080\/2162402X.2017.1371399","volume":"7","author":"K Catakovic","year":"2017","unstructured":"Catakovic, K. et al. TIGIT expressing CD4+ T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia. Oncoimmunology 7, e1371399 (2017).","journal-title":"Oncoimmunology"},{"key":"47024_CR20","doi-asserted-by":"crossref","unstructured":"Guillerey, C. et al. TIGIT immune checkpoint blockade restores CD8(+) T cell immunity against multiple myeloma. Blood (2018).","DOI":"10.1182\/blood-2018-01-825265"},{"key":"47024_CR21","doi-asserted-by":"publisher","first-page":"e1005349","DOI":"10.1371\/journal.ppat.1005349","volume":"12","author":"GM Chew","year":"2016","unstructured":"Chew, G. M. et al. TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection. PLoS Pathog 12, e1005349 (2016).","journal-title":"PLoS Pathog"},{"key":"47024_CR22","doi-asserted-by":"publisher","first-page":"e1466769","DOI":"10.1080\/2162402X.2018.1466769","volume":"7","author":"AL Hung","year":"2018","unstructured":"Hung, A. L. et al. TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM. Oncoimmunology 7, e1466769 (2018).","journal-title":"Oncoimmunology"},{"key":"47024_CR23","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.4049\/jimmunol.1300013","volume":"191","author":"T Boettler","year":"2013","unstructured":"Boettler, T. et al. Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1. J Immunol 191, 5026\u20135035 (2013).","journal-title":"J Immunol"},{"key":"47024_CR24","doi-asserted-by":"publisher","first-page":"e1002913","DOI":"10.1371\/journal.ppat.1002913","volume":"8","author":"T Boettler","year":"2012","unstructured":"Boettler, T. et al. OX40 facilitates control of a persistent virus infection. PLoS Pathog 8, e1002913 (2012).","journal-title":"PLoS Pathog"},{"key":"47024_CR25","doi-asserted-by":"publisher","first-page":"9122","DOI":"10.1128\/JVI.00639-09","volume":"83","author":"L Golden-Mason","year":"2009","unstructured":"Golden-Mason, L. et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. Journal of virology 83, 9122\u20139130 (2009).","journal-title":"Journal of virology"},{"key":"47024_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.aae0491","volume":"354","author":"DR Sen","year":"2016","unstructured":"Sen, D. R. et al. The epigenetic landscape of T cell exhaustion. Science 354, 1165\u20131169 (2016).","journal-title":"Science"},{"key":"47024_CR27","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.4049\/jimmunol.181.12.8215","volume":"181","author":"A Rutebemberwa","year":"2008","unstructured":"Rutebemberwa, A. et al. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol 181, 8215\u20138225 (2008).","journal-title":"J Immunol"},{"key":"47024_CR28","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto, N. et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog 5, e1000313 (2009).","journal-title":"PLoS Pathog"},{"key":"47024_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ccell.2014.11.016","volume":"26","author":"KE Pauken","year":"2014","unstructured":"Pauken, K. E. & Wherry, E. J. TIGIT and CD226: tipping the balance between costimulatory and coinhibitory molecules to augment the cancer immunotherapy toolkit. Cancer Cell 26, 785\u2013787 (2014).","journal-title":"Cancer Cell"},{"key":"47024_CR30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/eji.200940234","volume":"40","author":"M Cella","year":"2010","unstructured":"Cella, M. et al. Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection. Eur J Immunol 40, 949\u2013954 (2010).","journal-title":"Eur J Immunol"},{"key":"47024_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15, 486\u2013499 (2015).","journal-title":"Nat Rev Immunol"},{"key":"47024_CR32","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"HT Jin","year":"2010","unstructured":"Jin, H. T. et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 107, 14733\u201314738 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"47024_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/intimm\/dxp107","volume":"22","author":"K Richter","year":"2010","unstructured":"Richter, K., Agnellini, P. & Oxenius, A. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection. Int Immunol 22, 13\u201323 (2010).","journal-title":"Int Immunol"},{"key":"47024_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.virol.2012.04.006","volume":"429","author":"MJ Welch","year":"2012","unstructured":"Welch, M. J., Teijaro, J. R., Lewicki, H. A., Colonna, M. & Oldstone, M. B. CD8 T cell defect of TNF-alpha and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection. Virology 429, 163\u2013170 (2012).","journal-title":"Virology"},{"key":"47024_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/ni0208-122","volume":"9","author":"J Kaye","year":"2008","unstructured":"Kaye, J. CD160 and BTLA: LIGHTs out for CD4+ T cells. Nat Immunol 9, 122\u2013124 (2008).","journal-title":"Nat Immunol"},{"key":"47024_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2014.08.008","volume":"62","author":"S Owusu Sekyere","year":"2015","unstructured":"Owusu Sekyere, S. et al. A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C. J Hepatol 62, 31\u201340 (2015).","journal-title":"J Hepatol"},{"key":"47024_CR37","doi-asserted-by":"publisher","first-page":"9249","DOI":"10.1128\/JVI.00409-07","volume":"81","author":"L Golden-Mason","year":"2007","unstructured":"Golden-Mason, L. et al. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. Journal of virology 81, 9249\u20139258 (2007).","journal-title":"Journal of virology"},{"key":"47024_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.002","volume":"313","author":"M Barathan","year":"2017","unstructured":"Barathan, M. et al. CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptides. Cell Immunol 313, 1\u20139 (2017).","journal-title":"Cell Immunol"},{"key":"47024_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22659-1","volume":"8","author":"A Abel","year":"2018","unstructured":"Abel, A. et al. Differential expression pattern of co-inhibitory molecules on CD4(+) T cells in uncomplicated versus complicated malaria. Sci Rep 8, 4789 (2018).","journal-title":"Sci Rep"},{"key":"47024_CR40","doi-asserted-by":"publisher","first-page":"e105703","DOI":"10.1371\/journal.pone.0105703","volume":"9","author":"B Raziorrouh","year":"2014","unstructured":"Raziorrouh, B. et al. Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules. PLoS One 9, e105703 (2014).","journal-title":"PLoS One"},{"key":"47024_CR41","doi-asserted-by":"publisher","first-page":"e1005761","DOI":"10.1371\/journal.ppat.1005761","volume":"12","author":"R Fromentin","year":"2016","unstructured":"Fromentin, R. et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog 12, e1005761 (2016).","journal-title":"PLoS Pathog"},{"key":"47024_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1172\/JCI200318509","volume":"112","author":"CL Day","year":"2003","unstructured":"Day, C. L. et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 112, 831\u2013842 (2003).","journal-title":"J Clin Invest"},{"key":"47024_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.21015","volume":"79","author":"M Roederer","year":"2011","unstructured":"Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79, 167\u2013174 (2011).","journal-title":"Cytometry A"},{"key":"47024_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","volume":"10","author":"X Yu","year":"2009","unstructured":"Yu, X. et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 10, 48\u201357 (2009).","journal-title":"Nat Immunol"},{"key":"47024_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep40354","volume":"7","author":"J Tauriainen","year":"2017","unstructured":"Tauriainen, J. et al. Perturbed CD8(+) T cell TIGIT\/CD226\/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep 7, 40354 (2017).","journal-title":"Sci Rep"},{"key":"47024_CR46","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","volume":"346","author":"HM Diepolder","year":"1995","unstructured":"Diepolder, H. M. et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006\u20131007 (1995).","journal-title":"Lancet"},{"key":"47024_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/jhep.2001.21162","volume":"33","author":"KM Chang","year":"2001","unstructured":"Chang, K. M. et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33, 267\u2013276 (2001).","journal-title":"Hepatology"},{"key":"47024_CR48","doi-asserted-by":"publisher","first-page":"12584","DOI":"10.1128\/JVI.76.24.12584-12595.2002","volume":"76","author":"CL Day","year":"2002","unstructured":"Day, C. L. et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. Journal of virology 76, 12584\u201312595 (2002).","journal-title":"Journal of virology"},{"key":"47024_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat Immunol 12, 492\u2013499 (2011).","journal-title":"Nat Immunol"},{"key":"47024_CR50","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00262-018-2246-5","volume":"67","author":"BL Solomon","year":"2018","unstructured":"Solomon, B. L. & Garrido-Laguna, I. TIGIT: a novel immunotherapy target moving from bench to bedside. Cancer Immunol Immunother 67, 1659\u20131667 (2018).","journal-title":"Cancer Immunol Immunother"},{"key":"47024_CR51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jhep.2016.09.004","volume":"66","author":"P Ingiliz","year":"2017","unstructured":"Ingiliz, P. et al. HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe. J Hepatol 66, 282\u2013287 (2017).","journal-title":"J Hepatol"},{"key":"47024_CR52","doi-asserted-by":"crossref","unstructured":"Fourcade, J. et al. CD226 opposes TIGIT to disrupt Tregs in melanoma. JCI Insight 3 (2018).","DOI":"10.1172\/jci.insight.121157"},{"key":"47024_CR53","doi-asserted-by":"publisher","first-page":"E908","DOI":"10.1073\/pnas.1619059114","volume":"114","author":"CC Gross","year":"2017","unstructured":"Gross, C. C. et al. Haplotype matters: CD226 polymorphism as a potential trigger for impaired immune regulation in multiple sclerosis REPLY. P Natl Acad Sci USA 114, E908\u2013E909 (2017).","journal-title":"P Natl Acad Sci USA"},{"key":"47024_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford, A. et al. Molecular and transcriptional basis of CD4(+) T cell dysfunction during chronic infection. Immunity 40, 289\u2013302 (2014).","journal-title":"Immunity"},{"key":"47024_CR55","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1172\/JCI26856","volume":"116","author":"DG Brooks","year":"2006","unstructured":"Brooks, D. G., McGavern, D. B. & Oldstone, M. B. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest 116, 1675\u20131685 (2006).","journal-title":"J Clin Invest"},{"key":"47024_CR56","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1086\/651606","volume":"201","author":"TL Mosbruger","year":"2010","unstructured":"Mosbruger, T. L. et al. Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. J Infect Dis 201, 1371\u20131380 (2010).","journal-title":"J Infect Dis"},{"key":"47024_CR57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.humimm.2016.10.014","volume":"78","author":"MC da Costa Lima Caniatti","year":"2017","unstructured":"da Costa Lima Caniatti, M. C., Borelli, S. D., Guilherme, A. L. & Tsuneto, L. T. Association between HLA genes and dust mite sensitivity in a Brazilian population. Hum Immunol 78, 88\u201394 (2017).","journal-title":"Hum Immunol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47024-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:47:50Z","timestamp":1671259670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47024-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47024"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47024-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10624"}}